Literature DB >> 13944636

Blood fibrinolytic activity in diabetes mellitus and its bearing on ischaemic heart disease and obesity.

G R FEARNLEY, R CHAKRABARTI, P R AVIS.   

Abstract

Entities:  

Keywords:  CORONARY DISEASE; DIABETES MELLITUS; FIBRINOLYSIS; OBESITY IN DIABETES

Mesh：

Year:  1963        PMID： 13944636      PMCID： PMC2122789          DOI： 10.1136/bmj.1.5335.921

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  11 in total

1.  The intravenous glucose tolerance test in atherosclerotic disease with special reference to obestity hypertension, diabetic heredity and cholesterol values.

Authors:  F WAHLBERG
Journal:  Acta Med Scand       Date:  1962-01

2.  The effects of chlorpropamide on intermittent claudication and fibrinolysis.

Authors:  M J TSAPOGAS; L T COTTON; P T FLUTE; J G MURRAY
Journal:  Lancet       Date:  1962-06-09       Impact factor: 79.321

3.  Effect of the sulphonylureas on fibrinolysis.

Authors:  G R FEARNLEY; R CHAKRABARTI; C T VINCENT
Journal:  Lancet       Date:  1960-09-17       Impact factor: 79.321

4.  Presence of fibrinolytic activity in whole blood, masked by the clotting process.

Authors:  G R FEARNLEY; J FERGUSON
Journal:  Clin Sci       Date:  1958-11       Impact factor: 6.124

5.  Variation in fibrinolytic activity after acute myocardial infarction and after the administration of oral anticoagulant drugs and intravenous heparin.

Authors:  H LACKNER; C MERSKEY
Journal:  Br J Haematol       Date:  1960-10       Impact factor: 6.998

6.  Lipaemia in blood-coagulation defects in relation to ischaemic heart-disease.

Authors:  D C JAMES; J DRYSDALE; J D BILLIMORIA; D WHEATLEY; C J GAVEY; N F MACLAGAN
Journal:  Lancet       Date:  1961-10-07       Impact factor: 79.321

7.  Fibrinolytic activity of the blood in intermittent claudication.

Authors:  P J NESTEL
Journal:  Lancet       Date:  1959-09-19       Impact factor: 79.321

8.  Fibrinolysis in myocardial infarction.

Authors:  R HUME
Journal:  Br Heart J       Date:  1958-01

9.  Fibrinolysis by adsorption.

Authors:  G R FEARNLEY
Journal:  Nature       Date:  1953-09-19       Impact factor: 49.962

10.  Serum Mucoproteins and Plasma Fibrinolytic Activity in Coronary-artery Disease.

Authors:  D Ogston
Journal:  Br Med J       Date:  1962-05-05
View more
  25 in total

1.  GLUCOSE-TOLERANCE TEST IN HYPERTENSIVE PATIENTS.

Authors:  E R NYE
Journal:  Br Med J       Date:  1964-09-19

2.  Thrombolytic Therapy.

Authors: 
Journal:  Br Med J       Date:  1963-06-08

3.  Glucose intolerance, diabetes mellitus and atherosclerosis; prospects for prevention.

Authors:  H Keen
Journal:  Postgrad Med J       Date:  1976-07       Impact factor: 2.401

4.  Chlorpropamide and fibrinolytic activity in maturity onset diabetes mellitus.

Authors:  W D Alexander; R T Wensley; G Price; M Hartog
Journal:  Postgrad Med J       Date:  1976-05       Impact factor: 2.401

5.  Pharmacological fibrinolysis in diabetes mellitus.

Authors:  R Chakrabarti; G R Fearnley
Journal:  Diabetologia       Date:  1974-02       Impact factor: 10.122

6.  Fibrinolytic response to moderate exercise in 50 healthy middle-aged subjects.

Authors:  J D Cash; D G Woodfield
Journal:  Br Med J       Date:  1968-06-15

7.  Platelet adhesiveness, plasma fibrinogen and factor 8 levels in diabetes mellitus.

Authors:  E E Mayne; J M Bridges; J A Weaver
Journal:  Diabetologia       Date:  1970-08       Impact factor: 10.122

8.  Effect of atromid-S on fibrinolytic activity in patients with ischaemic heart disease and normal blood cholesterol levels.

Authors:  J M Goodhart; H A Dewar
Journal:  Br Med J       Date:  1966-02-05

Review 9.  [Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].

Authors:  H Zöller
Journal:  Klin Wochenschr       Date:  1978-08-15

10.  Blood glucose may condition factor VII levels in diabetic and normal subjects.

Authors:  A Ceriello; D Giugliano; A Quatraro; P Dello Russo; R Torella
Journal:  Diabetologia       Date:  1988-12       Impact factor: 10.122
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.